What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cancer
His main research concerns Surgery, Internal medicine, Colorectal cancer, Cancer and Survival rate.
Surgery is closely attributed to Hyperthermic intraperitoneal chemotherapy in his work.
David L. Morris combines subjects such as Gastroenterology, Endocrinology and Oncology with his study of Internal medicine.
His study in Colorectal cancer is interdisciplinary in nature, drawing from both Percutaneous, Radiology, Radiofrequency ablation, Metastasis and Lung.
His Cancer study combines topics from a wide range of disciplines, such as Laparoscopy and Immunology.
David L. Morris has included themes like Prognostic variable, Prospective cohort study, Retrospective cohort study, Hepatectomy and Survival analysis in his Survival rate study.
His most cited work include:
- Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (611 citations)
- Tissue surface treatment apparatus and method (532 citations)
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience (451 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Surgery, Internal medicine, Colorectal cancer, Gastroenterology and Chemotherapy.
His studies in Surgery integrate themes in fields like Hyperthermic intraperitoneal chemotherapy and Cytoreductive surgery.
The study incorporates disciplines such as Peritoneal Cancer Index, Pseudomyxoma peritonei and Peritoneal mesothelioma in addition to Hyperthermic intraperitoneal chemotherapy.
The various areas that David L. Morris examines in his Internal medicine study include Endocrinology and Oncology.
His work is dedicated to discovering how Colorectal cancer, Radiology are connected with Lung and other disciplines.
His biological study spans a wide range of topics, including Surgical oncology and Retrospective cohort study.
He most often published in these fields:
- Surgery (42.44%)
- Internal medicine (31.53%)
- Colorectal cancer (20.24%)
What were the highlights of his more recent work (between 2014-2021)?
- Surgery (42.44%)
- Internal medicine (31.53%)
- Hyperthermic intraperitoneal chemotherapy (12.31%)
In recent papers he was focusing on the following fields of study:
David L. Morris mostly deals with Surgery, Internal medicine, Hyperthermic intraperitoneal chemotherapy, Cytoreductive surgery and Colorectal cancer.
He focuses mostly in the field of Surgery, narrowing it down to matters related to Peritonectomy and, in some cases, Radiology.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Oncology.
David L. Morris interconnects Incidence, Peritoneal Cancer Index, Peritoneal surface, Pseudomyxoma peritonei and Surgical oncology in the investigation of issues within Hyperthermic intraperitoneal chemotherapy.
His study explores the link between Cytoreductive surgery and topics such as Retrospective cohort study that cross with problems in Peritoneal Neoplasm and Surgical team.
His Colorectal cancer research includes themes of Carcinoembryonic antigen and Resection.
Between 2014 and 2021, his most popular works were:
- Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus (387 citations)
- Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus (169 citations)
- Transancestral mapping and genetic load in systemic lupus erythematosus (143 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Cancer
David L. Morris mainly focuses on Internal medicine, Surgery, Hyperthermic intraperitoneal chemotherapy, Colorectal cancer and Conventional PCI.
His research in Internal medicine intersects with topics in Gastroenterology and Oncology.
David L. Morris has researched Oncology in several fields, including Combined Modality Therapy and Peritoneal carcinomatosis.
His work carried out in the field of Surgery brings together such families of science as Cytoreductive surgery, Peritoneal Cancer Index and Pseudomyxoma peritonei.
His Hyperthermic intraperitoneal chemotherapy research is multidisciplinary, incorporating perspectives in Chemotherapy, Peritoneal mesothelioma, Peritoneal surface, Confidence interval and Surgical oncology.
His work deals with themes such as Hepatocellular carcinoma, Carcinoembryonic antigen, Carcinoma and Hazard ratio, which intersect with Colorectal cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
